Login / Signup

Efficacy profile of the CYD-TDV dengue vaccine revealed by Bayesian survival analysis of individual-level phase III data.

Daniel J LaydonIlaria DorigattiWes R HinsleyGemma Nedjati-GilaniLaurent CoudevilleNeil M Ferguson
Published in: eLife (2021)
NCT01373281 and NCT01374516.
Keyphrases
  • phase iii
  • open label
  • clinical trial
  • zika virus
  • double blind
  • dengue virus
  • electronic health record
  • aedes aegypti
  • phase ii
  • placebo controlled
  • big data
  • free survival
  • randomized controlled trial